Adline Chem Lab Ltd - 524604 - Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting - Intimation Of Date Of Annual General Meeting, Book Closure & E-Voting.
The Board of Directors in their meeting held today have decided to convene Annual General Meeting of the Company on Friday, the 16th September, 2022 at 12.00 Noon through Video Conferencing (VC)/ Other Audio Visual Means (OAVM). Adline Chem Lab Ltd - 524604 - Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Kamlesh LaskariDesignation :- Managing Director / Whole Time Director Adline Chem Lab Ltd - 524604 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we are hereby submitting the certificate issued by Link In time India Private Limited, Registrar and Share Transfer Agent of the Company for the Quarter ended on 30th June, 2022. Adline Chem Lab Ltd - 524604 - Closure of Trading Window
Pursuant to BSE's Circular No. LIST/COMP/01/2019-20 dated 2nd April, 2019 and as per Clause 4 of the Schedule B and other applicable regulations of SEBI (Prohibition of Insider Trading) Regulations, 2015, this is to inform you that in terms of Company's Code of Conduct for Prevention of Insider Trading the Trading Window of the Company will remain closed with effect from 1st July, 2022 till 48 hours after the declaration of Unaudited Financial Results for the quarter ended on 30th June, 2022 Adline Chem Lab Ltd - 524604 - Results- Financial Result For Mar 31, 2022
Please note that the Board of Directors in their meeting held today i.e. on 27th May, 2022, have approved the Audited Financial Results for the financial year 2021-22 ended on 31st March, 2022. Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, we are enclosing herewith: 1. Statement of Audited Financial Results for the year ended on 31st March, 2022. 2. Auditors' Report on the Audited Financial Results 3. Declaration to the effect that there is Unmodified Opinion with respect to Audited Financial Results for the year ended on 31st March, 2022 Adline Chem Lab Ltd - 524604 - Board Meeting Outcome for Board Meeting Outcome For Submission Of Audited Financial Results For The Financial Year Ended On 31St March, 2022
Please note that the Board of Directors in their meeting held today i.e. on 27th May, 2022, have approved the Audited Financial Results for the financial year 2021-22 ended on 31st March, 2022. Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, we are enclosing herewith: 1. Statement of Audited Financial Results for the year ended on 31st March, 2022. 2. Auditors' Report on the Audited Financial Results 3. Declaration to the effect that there is Unmodified Opinion with respect to Audited Financial Results for the year ended on 31st March, 2022 Adline Chem Lab Ltd - 524604 - Board Meeting Intimation for Consideration Of Standalone Audited Financial Results For The Financial Year 2021-22 Ended On 31St March, 2022
Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2022 ,inter alia, to consider and approve the Standalone Audited Financial Results of the Company for the Financial Year 2021 22 ended on 31st March, 2022 is scheduled to be held on 27th May, 2022. Adline Chem Lab Ltd - 524604 - Announcement Under Regulation 30 (LODR)- Updates- Declaration With Respect To Non - Applicability Of Large Entities Framework
Pursuant to SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated 26th November, 2018 for fund raising by issuance of debt securities by Large Entities and compliances thereof, We hereby submit that our Company is out of purview of Large Corporate category as per the applicability of framework provided in the aforesaid circular. Adline Chem Lab Ltd - 524604 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayAdline Chem Lab Ltd 2CINL24231GJ1988PLC010956 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Bhavasthi R Mehta Designation: Company Secretary & Compliance officer EmailId: [email protected] Name of the Chief Financial Officer: Sohan K Laskari Designation: Chief Financial officer EmailId: [email protected] Date: 29/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.